| scholarly article | Q13442814 |
| P2093 | author name string | Naoki Hosen | |
| Kana Hasegawa | |||
| Haruo Sugiyama | |||
| Akihiro Tsuboi | |||
| Jun Nakata | |||
| Sumiyuki Nishida | |||
| Yoshihiro Oka | |||
| Yusuke Oji | |||
| Fumihiro Fujiki | |||
| Hiroko Nakajima | |||
| Soyoko Morimoto | |||
| Mayuko Adachi | |||
| Sayaka Ikejima | |||
| Sae Hayashi | |||
| Rin Imanishi | |||
| P2860 | cites work | Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | Q27860650 |
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer | Q29620902 | ||
| Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination | Q34068404 | ||
| Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide | Q37384745 | ||
| Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression | Q37535549 | ||
| WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. | Q38302906 | ||
| A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. | Q38360653 | ||
| Immunomonitoring in glioma immunotherapy: current status and future perspectives | Q38659771 | ||
| Immunotherapy for Esophageal and Gastric Cancer | Q38676783 | ||
| Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma | Q38837680 | ||
| First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. | Q39388286 | ||
| Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS. | Q40071910 | ||
| Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway | Q40308394 | ||
| Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors | Q40500190 | ||
| Oxygen‐regulated expression of the Wilms’ tumor suppressorWt1involves hypoxia‐inducible factor‐1 (HIF‐1) | Q40648946 | ||
| Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells | Q41043863 | ||
| Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials | Q41987317 | ||
| WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient | Q42969565 | ||
| Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia | Q43297784 | ||
| Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial | Q44235754 | ||
| Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents | Q45367799 | ||
| Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. | Q46739397 | ||
| Combination gemcitabine and WT1 peptide vaccination improves progression-free survival in advanced pancreatic ductal adenocarcinoma: A phase II randomized study | Q47650715 | ||
| WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies. | Q47660274 | ||
| Towards personalized, tumour-specific, therapeutic vaccines for cancer. | Q47789519 | ||
| A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. | Q47953114 | ||
| The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review | Q49885285 | ||
| Benefit of ELISpot in early diagnosis of tuberculous meningoencephalitis: Case report and literature review | Q50223383 | ||
| A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma. | Q54046740 | ||
| Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma. | Q55629068 | ||
| Therapeutic cancer vaccine: building the future from lessons of the past | Q57177129 | ||
| Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1 | Q57601754 | ||
| Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapies | Q59789596 | ||
| Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis | Q64108502 | ||
| Cancer immunotherapy targeting Wilms' tumor gene WT1 product | Q73407012 | ||
| Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers | Q74456077 | ||
| Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro | Q83185544 | ||
| Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients | Q88073240 | ||
| ASCO 2018 NSCLC highlights-combination therapy is key | Q90816464 | ||
| Use of Immune Checkpoint Inhibitors in Mesothelioma | Q91569214 | ||
| Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial | Q92570753 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 5 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 244-250 | |
| P577 | publication date | 2020-03-05 | |
| P1433 | published in | Biomedical Reports | Q26853995 |
| P1476 | title | Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy | |
| P478 | volume | 12 |
| Q98466244 | Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review | cites work | P2860 |
Search more.